My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 109

    1.

    Trading people versus trading time: what is the difference?

    Damschroder LJ, Roberts TR, Goldstein CC, Miklosovic ME, Ubel PA.

    Popul Health Metr. 2005 Nov 10;3:10.PMID: 16281982 [PubMed]Related articlesFree article

    2.

    Value measurement in cost-utility analysis: explaining the discrepancy between rating scale and person trade-off elicitations.

    Ubel PA, Loewenstein G, Scanlon D, Kamlet M.

    Health Policy. 1998 Jan;43(1):33-44.PMID: 10178799 [PubMed - indexed for MEDLINE]Related articles

    3.

    Exploring the role of order effects in person trade-off elicitations.

    Ubel PA, Richardson J, Baron J.

    Health Policy. 2002 Aug;61(2):189-99.PMID: 12088891 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lack of multiplicative transitivity in person trade-off responses.

    Schwarzinger M, Lanoë JL, Nord E, Durand-Zaleski I.

    Health Econ. 2004 Feb;13(2):171-81.PMID: 14737754 [PubMed - indexed for MEDLINE]Related articles

    5.

    Why people refuse to make tradeoffs in person tradeoff elicitations: a matter of perspective?

    Damschroder LJ, Roberts TR, Zikmund-Fisher BJ, Ubel PA.

    Med Decis Making. 2007 May-Jun;27(3):266-80.PMID: 17545497 [PubMed - indexed for MEDLINE]Related articles

    6.

    Utility assessment in patients with mental disorders: validity and discriminative ability of the time trade-off method.

    König HH, Günther OH, Angermeyer MC, Roick C.

    Pharmacoeconomics. 2009;27(5):405-19. doi: 10.2165/00019053-200927050-00005.PMID: 19586078 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cross-national agreement on disability weights: the European Disability Weights Project.

    Schwarzinger M, Stouthard ME, Burström K, Nord E.

    Popul Health Metr. 2003 Nov 21;1(1):9.PMID: 14633276 [PubMed - as supplied by publisher]Related articlesFree article

    8.

    Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

    Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.

    Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.PMID: 16545208 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.

    Shepherd J, Jones J, Takeda A, Davidson P, Price A.

    Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. Review.PMID: 16904047 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The cost-effectiveness of testing for hepatitis C in former injecting drug users.

    Castelnuovo E, Thompson-Coon J, Pitt M, Cramp M, Siebert U, Price A, Stein K.

    Health Technol Assess. 2006 Sep;10(32):iii-iv, ix-xii, 1-93.PMID: 16948891 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.

    Ossa DF, Briggs A, McIntosh E, Cowell W, Littlewood T, Sculpher M.

    Pharmacoeconomics. 2007;25(3):223-37.PMID: 17335308 [PubMed - indexed for MEDLINE]Related articles

    12.

    The equivalence of numbers: the social value of avoiding health decline: an experimental Web-based study.

    Schwappach DL.

    BMC Med Inform Decis Mak. 2002;2:3. Epub 2002 Mar 5.PMID: 11879529 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Valuing health-related quality of life. A review of health state valuation techniques.

    Green C, Brazier J, Deverill M.

    Pharmacoeconomics. 2000 Feb;17(2):151-65. Review.PMID: 10947338 [PubMed - indexed for MEDLINE]Related articles

    14.

    Balancing urgency, age and quality of life in organ allocation decisions--what would you do? A survey.

    Stahl JE, Tramontano AC, Swan JS, Cohen BJ.

    J Med Ethics. 2008 Feb;34(2):109-15.PMID: 18234950 [PubMed - indexed for MEDLINE]Related articles

    15.

    Rating scale, standard gamble, and time trade-off for people with traumatic spinal cord injuries.

    Lin MR, Hwang HF, Chung KP, Huang C, Chen CY.

    Phys Ther. 2006 Mar;86(3):337-44.PMID: 16506870 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Using the person trade-off approach to examine differences between individual and social values.

    Dolan P, Green C.

    Health Econ. 1998 Jun;7(4):307-12.PMID: 9683091 [PubMed - indexed for MEDLINE]Related articles

    18.

    On the (not so) constant proportional trade-off in TTO.

    Attema AE, Brouwer WB.

    Qual Life Res. 2010 Feb 12. [Epub ahead of print]PMID: 20151207 [PubMed - as supplied by publisher]Related articles

    19.

    Modeling ranking, time trade-off, and visual analog scale values for EQ-5D health states: a review and comparison of methods.

    Craig BM, Busschbach JJ, Salomon JA.

    Med Care. 2009 Jun;47(6):634-41.PMID: 19433996 [PubMed - indexed for MEDLINE]Related articles

    20.

    The person trade-off method and the transitivity principle: an example from preferences over age weighting.

    Dolan P, Tsuchiya A.

    Health Econ. 2003 Jun;12(6):505-10.PMID: 12759919 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk